Tumor necrosis factor-α inhibition improves endothelial function and decreases arterial stiffness in estrogen-deficient postmenopausal women
- 1 October 2013
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 230 (2) , 390-396
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Tetrahydrobiopterin improves endothelial function and decreases arterial stiffness in estrogen-deficient postmenopausal womenAmerican Journal of Physiology-Heart and Circulatory Physiology, 2012
- Aging is associated with greater nuclear NFκB, reduced IκBα, and increased expression of proinflammatory cytokines in vascular endothelial cells of healthy humansAging Cell, 2008
- Vasculoprotective Effects of Anti-Tumor Necrosis Factor-α Treatment in AgingThe American Journal of Pathology, 2007
- Oxidative stress explains differences in large elastic artery compliance between sedentary and habitually exercising postmenopausal womenMenopause, 2006
- Tetrahydrobiopterin correctsEscherichia coliendotoxin-induced endothelial dysfunctionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Chronic Tumor Necrosis Factor-α Inhibition Enhances NO Modulation of Vascular Function in Estrogen-Deficient RatsHypertension, 2005
- Ascorbic Acid Selectively Improves Large Elastic Artery Compliance in Postmenopausal WomenHypertension, 2005
- A Phase II Study of Etanercept (Enbrel), a Tumor Necrosis Factor α Inhibitor in Patients with Metastatic Breast CancerClinical Cancer Research, 2004
- Effects of Conjugated Equine Estrogen in Postmenopausal Women With HysterectomyJAMA, 2004
- Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease EnterprisesCirculation, 2003